KROS Keros Therapeutics, Inc.
Healthcare · Market cap: $204.2M
–
Bought and sold by quarter, last 5 years
Open-market purchases and sales by this company's insiders, in dollars, last 5 years
| Quarter | Bought | Sold |
|---|---|---|
| 2022-Q1 | $0 | $3.3M |
| 2022-Q2 | $0 | $1.2M |
| 2022-Q3 | $0 | $1.4M |
| 2022-Q4 | $0 | $0 |
| 2023-Q1 | $0 | $0 |
| 2023-Q2 | $0 | $1.9M |
| 2023-Q3 | $0 | $0 |
| 2023-Q4 | $0 | $1.8M |
| 2024-Q1 | $0 | $1.8M |
| 2024-Q2 | $0 | $0 |
| 2024-Q3 | $0 | $22.0M |
| 2024-Q4 | $0 | $0 |
| 2025-Q1 | $0 | $0 |
| 2025-Q2 | $9.5M | $0 |
| 2025-Q3 | $0 | $0 |
| 2025-Q4 | $0 | $180.6M |
| 2026-Q1 | $22.4K | $331.8K |
| 2026-Q2 | $32.5K | $90.0K |
| 2026-Q3 | $20.9K | $101.1K |
| 2026-Q4 | $0 | $0 |
Bought$9.5M7 buy days
Sold$217.3M38 sell days
Net insider flow-$207.8Mnet selling · 5 years
Latest trade2026-08-18Cho Esther
| Date | Side | Insider | Role | Shares | Avg price | Value | Trades |
|---|---|---|---|---|---|---|---|
| 2026-08-18 | Sell | Cho Esther | Other C-suite | 4,485 | $10.29 | $46.2K | 1 |
| 2026-08-18 | Sell | Lerner Lorena Raquel | Other C-suite | 3,568 | $10.29 | $36.7K | 1 |
| 2026-08-18 | Sell | Tanini Annita | VP | 1,224 | $10.29 | $12.6K | 1 |
| 2026-08-18 | Sell | Newton Charles W. | Director | 551 | $10.30 | $5.7K | 1 |
| 2026-08-17 | Buy | BIENAIME JEAN JACQUES | Director | 1,000 | $10.27 | $10.3K | 1 |
| 2026-07-15 | Buy | BIENAIME JEAN JACQUES | Director | 1,000 | $10.61 | $10.6K | 1 |
| 2026-06-15 | Buy | BIENAIME JEAN JACQUES | Director | 1,000 | $10.19 | $10.2K | 1 |
| 2026-06-11 | Sell | Newton Charles W. | Director | 550 | $10.04 | $5.5K | 1 |
| 2026-06-04 | Sell | Knowles Julius | Director | 2,625 | $10.73 | $28.2K | 1 |
| 2026-06-04 | Sell | Farzan Nima | Director | 2,625 | $10.73 | $28.2K | 1 |
| 2026-06-04 | Sell | Seth Alpna | Director | 2,625 | $10.72 | $28.1K | 1 |
| 2026-05-15 | Buy | BIENAIME JEAN JACQUES | Director | 1,000 | $10.58 | $10.6K | 1 |
| 2026-04-15 | Buy | BIENAIME JEAN JACQUES | Director | 1,000 | $11.70 | $11.7K | 1 |
| 2026-03-09 | Buy | BIENAIME JEAN JACQUES | Director | 2,000 | $11.21 | $22.4K | 1 |
| 2026-02-19 | Sell | Seehra Jasbir | CEO | 7,015 | $16.17 | $113.4K | 1 |
| 2026-02-18 | Sell | Cho Esther | General counsel | 4,745 | $16.35 | $77.6K | 1 |
| 2026-02-18 | Sell | Regnante Keith | CFO | 4,739 | $16.35 | $77.5K | 1 |
| 2026-02-18 | Sell | Lerner Lorena Raquel | Other C-suite | 3,873 | $16.35 | $63.3K | 1 |
| 2025-10-15 | Sell | ADAR1 Partners, LP | 10% owner | 5,389,264 | $17.75 | $95.7M | 3 |
| 2025-10-15 | Sell | Kariv Tomer | Director | 4,787,331 | $17.75 | $85.0M | 4 |
| 2025-04-09 | Buy | ADAR1 Partners, LP | 10% owner | 934,258 | $10.13 | $9.5M | 5 |
| 2024-08-13 | Sell | GORDON CARL L | Director | 250,000 | $44.01 | $11.0M | 2 |
| 2024-08-13 | Sell | ORBIMED ADVISORS LLC | Director | 250,000 | $44.01 | $11.0M | 2 |
| 2024-01-04 | Sell | Regnante Keith | CFO | 40,000 | $45.29 | $1.8M | 1 |
| 2023-11-04 | Sell | Regnante Keith | CFO | 40,000 | $45.29 | $1.8M | 1 |
| 2023-06-09 | Sell | Regnante Keith | CFO | 20,000 | $45.42 | $908.4K | 3 |
| 2023-06-08 | Sell | Regnante Keith | CFO | 20,000 | $47.79 | $955.9K | 2 |
| 2022-07-15 | Sell | Lachey Jennifer | Other C-suite | 46,034 | $30.00 | $1.4M | 1 |
| 2022-07-13 | Sell | Lachey Jennifer | Other C-suite | 1,916 | $30.00 | $57.5K | 1 |
| 2022-05-11 | Sell | Lachey Jennifer | Other C-suite | 5,300 | $41.90 | $222.0K | 5 |
| 2022-04-11 | Sell | Lachey Jennifer | Other C-suite | 5,300 | $62.77 | $332.7K | 4 |
| 2022-04-06 | Sell | Rovaldi Christopher | COO | 1,728 | $65.00 | $112.3K | 1 |
| 2022-04-04 | Sell | Lachey Jennifer | Other C-suite | 7,950 | $60.00 | $477.0K | 1 |
| 2022-04-01 | Sell | Rovaldi Christopher | COO | 864 | $57.49 | $49.7K | 5 |
| 2022-03-11 | Sell | Lachey Jennifer | Other C-suite | 2,650 | $53.38 | $141.4K | 3 |
| 2022-02-11 | Sell | Lachey Jennifer | Other C-suite | 2,650 | $52.06 | $138.0K | 3 |
| 2022-01-11 | Sell | Lachey Jennifer | Other C-suite | 2,650 | $53.75 | $142.4K | 3 |
| 2022-01-05 | Sell | Knowles Julius | Director | 4,034 | $58.25 | $235.0K | 6 |
| 2022-01-05 | Sell | Lachey Jennifer | Other C-suite | 2,650 | $60.00 | $159.0K | 1 |
| 2022-01-04 | Sell | Knowles Julius | Director | 20,062 | $57.55 | $1.2M | 10 |
| 2022-01-03 | Sell | Knowles Julius | Director | 23,555 | $58.01 | $1.4M | 8 |
| 2021-12-15 | Sell | Lachey Jennifer | Other C-suite | 735 | $50.00 | $36.8K | 1 |
| 2021-12-13 | Sell | Lachey Jennifer | Other C-suite | 1,915 | $50.55 | $96.8K | 3 |
| 2021-12-02 | Sell | Knowles Julius | Director | 25,338 | $53.57 | $1.4M | 8 |
| 2021-12-01 | Sell | Knowles Julius | Director | 22,313 | $54.68 | $1.2M | 8 |
Who the insiders are, last 5 years
Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| ADAR1 Partners, LP | 10% owner | $9.5M | $95.7M | 2025-10-15 |
| Kariv Tomer | Director | $0 | $85.0M | 2025-10-15 |
| GORDON CARL L | Director | $0 | $11.0M | 2024-08-13 |
| ORBIMED ADVISORS LLC | Director | $0 | $11.0M | 2024-08-13 |
| Regnante Keith | CFO | $0 | $5.6M | 2026-02-18 |
| Knowles Julius | Director | $0 | $5.4M | 2026-06-04 |
| Lachey Jennifer | Other C-suite | $0 | $3.2M | 2022-07-15 |
| Rovaldi Christopher | COO | $0 | $162.0K | 2022-04-06 |
| Cho Esther | Other C-suite | $0 | $123.7K | 2026-08-18 |
| Seehra Jasbir | CEO | $0 | $113.4K | 2026-02-19 |
| Lerner Lorena Raquel | Other C-suite | $0 | $100.0K | 2026-08-18 |
| BIENAIME JEAN JACQUES | Director | $75.8K | $0 | 2026-08-17 |
| Farzan Nima | Director | $0 | $28.2K | 2026-06-04 |
| Seth Alpna | Director | $0 | $28.1K | 2026-06-04 |
| Tanini Annita | VP | $0 | $12.6K | 2026-08-18 |
| Newton Charles W. | Director | $0 | $11.2K | 2026-08-18 |
Past buying clusters
A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.
| Window | Insiders | Total | Score | 21 days vs benchmark | 63 days vs benchmark | 126 days vs benchmark | Status |
|---|---|---|---|---|---|---|---|
| 2020-04-13 | 7 | $23.2M | 62 | +21.2% (+21.4% raw) | +17.8% (+31.8% raw) | +80.0% (+106.5% raw) | closed |
Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.